GlassScriptPhysician profile
Aamir Mushtaq Rai
NPI 1558567289
$7,442.48
in general payments reported to CMS, 2019-2025
32 companies · $759 in 2025
The $759 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,750 · 2021: $86.22 · 2022: $894 · 2023: $719 · 2024: $1,234 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,702 · Education: $10.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,701.96 |
| Education | $10.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $3,750.00 | 2020 | |
| Medtronic, INC. | $889.50 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Osteocool Rf Ablation System |
| Si-Bone, INC. | $622.70 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $445.76 | 2022-2024 | Xtampza |
| Forte Bio-Pharma LLC | $389.20 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Nevro Corp. | $260.82 | 2022-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $207.97 | 2022-2024 | Relistor |
| Boston Scientific Corporation | $115.04 | 2023-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $70.71 | 2025 | Nalu Neurostimulation System |
| Biohaven Pharmaceutical Holding Company LTD. | $59.28 | 2022 | |
| Almatica Pharma LLC | $58.69 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $46.73 | 2022-2025 | |
| Averitas Pharma INC. | $44.20 | 2024-2025 | Qutenza |
| Pfizer INC. | $41.78 | 2023-2024 | |
| Valinor Pharma, LLC | $38.65 | 2023 | Movantik |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $38.64 | 2024 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $37.78 | 2022-2024 | Iovera, Zilretta |
| Biotronik Nro, INC. | $37.69 | 2023-2024 | Prospera, Biotronik |
| Globus Medical, INC. | $37.11 | 2025 | Senza |
| Abbvie INC. | $25.21 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $25.12 | 2022-2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $24.48 | 2025 | |
| Saluda Medical Americas, INC. | $23.80 | 2025 | Evoke |
| Arbor Pharmaceuticals, INC. | $23.13 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $21.31 | 2023 | Cios Select |
| Curonix LLC | $20.32 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lundbeck LLC | $18.22 | 2025 | Vyepti |
| Becton, Dickinson and Company | $14.75 | 2024 | Venclose Maven Catheter |
| Abbott Laboratories | $14.40 | 2024 | Eterna |
| Bioventus LLC | $13.79 | 2023 | Durolane |
| Azurity Pharmaceuticals, INC. | $13.34 | 2023 | Horizant |
| Biodelivery Sciences International, INC. | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aamir Rai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.